Siren Biotechnology announced it raised $19.6 Million in an initial filing from an offering of $32.4 Million
Siren Biotechnology announced it raised $19.6 Million in an initial filing from an offering of $32.4 Million
04/22/24, 5:29 PM
Location
Money raised
$19.6 million
Industry
biotechnology
Company Info
Location
455 mission bay boulevard south
san francisco, california, united states
Additional Info
The fight against cancer needs new, big, bold ideas. At Siren, we’ve got one: Universal AAV Immuno-Gene Therapy.
We are combining two transformative therapeutic technologies – AAV gene therapy and cytokine immunotherapy - into a single, reimagined modality that overcomes key challenges and redefines how we destroy tumor cells and elicit anti-tumor immunity.